Attitudinal questions about the role of pharmacy in the provision of CAM advice revealed that whilst only 11% of respondents reported their pharmacist aware of their use of CAM, and 52% agreed it important their pharmacist knowledgeable about CAM, only 25% felt their pharmacist currently to be a useful source of information. However, 55% reported they would use their pharmacist as a preferred source of information about CAM if they felt them more knowledgeable. 49% thought their pharmacist ought to be the most reliable source of information about

safety of CAMs and interactions with medication. However, 45% used their family and friends as their primary source of information about CAM. The results concur with Australian and Canadian studies that report customers expect pharmacists to be knowledgeable about CAMs selleck kinase inhibitor and provide an advisory role to help them assess information and communicate guidance about safety issues (2). However, whilst the study demonstrates many UK

customers selleck products expect their pharmacist to be knowledgeable about CAM and believe they should be a source of reliable safety information and advice regarding possible interactions with medications, they feel that there is a lack of understanding within the profession on the subject. This pilot investigation demonstrates the need for a larger scale study to better understand consumer’s more general and specific needs in greater detail together with a Interleukin-3 receptor parallel assessment of the requirements of community pharmacy to meet any identified demands in the context of an evidence based scenario. One place to begin to enhance the provision of good quality advice regarding CAM products may

be through the provision of CPD pharmacy training. 1. Cramer H. et al. Over the counter advice seeking about complementary and alternative medicines (CAM) in community pharmacies and health shops: an ethnographic study. Health and Social Care in the Community 2010; 18: 41–50. 2. Kwan D et al. Exploring consumer and pharmacist views on the professional role of the pharmacist with respect to natural health products: a study of focus groups. BMC Complement Altern Med 2008; 8: 40. Rebecca Dickinson1, DK Raynor1, Peter Knapp2, Jan MacDonald3 1University of Leeds, Leeds, UK, 2University of York, York, UK, 3Medicine and Healthcare products Regulatory Agency, London, UK This objective of this study was to explore whether patients use a headline section in a patient information leaflet to find key information about their medicines in a user-test. Quantitative findings showed the headline was used for 55/140 opportunities (39%), and qualitative findings suggested the headline was viewed as a positive inclusion. The headline section was only used just over a third of the time, but its inclusion was viewed as a valuable addition. European legislation requires a PIL be provided with each licensed medicine.